低剂量螺旋CT肺癌筛查及肺结节的研究现状

doi:10.11904/j.issn.1002-3070.2018.01.013

实用肿瘤学杂志 ›› 2018, Vol. 32 ›› Issue (1): 68-72.doi: 10.11904/j.issn.1002-3070.2018.01.013

低剂量螺旋CT肺癌筛查及肺结节的研究现状

孔维嘉, 安甜, 吕博综述, 姜广建审校

北京中医药大学(北京 10000)

收稿日期:2017-11-08 出版日期:2018-02-20 发布日期:2018-03-07
通讯作者: 姜广建,E-mail:guangjianjiang@sina.com
作者简介:孔维嘉,女,(1998-),本硕连读,从事肺癌筛查及中医药治疗的研究。

Current status:low dose spiral CT lung screening and pulmonary nodules

KONG Weijia, AN Tian, LV Bo, JIANG Guangjian

Beijing University of Chinese Medicine,Beijing 100000,China

Received:2017-11-08 Online:2018-02-20 Published:2018-03-07

摘要/Abstract

摘要： 肺癌已经成为对人类生命威胁最大的恶性肿瘤之一,其发病和死亡均居恶性肿瘤首位,因此对肺癌的筛查显得尤为重要。随着低剂量螺旋CT的广泛应用,肺结节的检出率在不断增加,对其研究也在不断深入。本文就肺癌筛查的现况、肺结节良恶性影响因素做一阐述,以期为肺癌和肺结节的防治提供依据。

关键词: 肺癌筛查, 肺结节, 低剂量螺旋CT

Abstract: Lung cancer has become one of the most threatening malignant tumors in human life.Its morbidity and mortality rank is the first place in malignant tumors,so it is particularly important to screen for lung cancer.With the widespread use of low-dose CT,the detection rate of pulmonary nodules is increasing,and its research is also in-depth.This article described the status of lung cancer screening,factors of benign and malignant pulmonary nodules.It could provide the basis information for prevention and treatment of the lung cancer and pulmonary nodules.

Key words: Long cancer screening, Pulmonary nodules, Low-dose computed tomography

中图分类号:

R734.1

孔维嘉, 安甜, 吕博, 姜广建. 低剂量螺旋CT肺癌筛查及肺结节的研究现状[J]. 实用肿瘤学杂志, 2018, 32(1): 68-72.

KONG Weijia, AN Tian, LV Bo, JIANG Guangjian. Current status:low dose spiral CT lung screening and pulmonary nodules[J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(1): 68-72.

参考文献

1 Ferlay J,Soerjomataram I,Dikshit R,et al.Cancer incidence and mortality worldwide:sources,methods and major patterns in GLOBOCAN 2012[J].Int J Cancer,2015,136(5):359-386.
2 Zheng R,Zeng H,Zhang S,et al.Estimates of cancer incidence and mortality in China,2013[J].Chin J Cancer,2017,36(1):66.
3 Allemani C,Weir HK,Carreira H,et al.Global surveillance of cancer survival 1995-2009:analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries(CONCORD-2)[J].Lancet,2015,385(9972):977-1010.
4 Blandin Knight S,Crosbie PA,Balata H,et al.Progress and prospects of early detection in lung cancer[J].Open Biol,2017,7(9):170070.
5 Ost DE,Gould MK.Decision making in patients with pulmonary nodules[J].Am J Respir Crit Care Med,2012,185(4):363-372.
6 Chen W,Zheng R,Zhang S,et al.Cancer incidence and mortality in China in 2013:an analysis based on urbanization level[J].Chin J Cancer Res,2017,29(1):1-10.
7 Chen W,Zheng R,Baade PD,et al.Cancer statistics in China,2015[J].CA Cancer J Clin,2016,66(2):115-132.
8 Global Burden of Disease Cancer Collaboration,Fitzmaurice C,Dicker D,et al.The global burden of cancer 2013[J].JAMA Oncol,2015,1(4):505-527.
9 National Lung Screening Trial Research Team,Aberle DR,Adams AM,et al.Reduced lung-cancer mortality with low-dose computed tomographic screening[J].N Engl J Med,2011,365(5):395-409.
10 Sheehan DF,Criss SD,Gazelle GS,et al.Evaluating lung cancer screening in China:Implications for eligibility criteria design from a microsimulation modeling approach[J].PLoS One,2017,12(3):e0173119.
11 Hu J,Qian GS,Bai CX,et al.Chinese consensus on early diagnosis of primary lung cancer(2014 version)[J].Cancer,2015,121(17):3157-3164.
12 Gould MK,Donington J,Lynch WR,et al.Evaluation of individuals with pulmonary nodules:when is it lung cancer? Diagnosis and management of lung cancer,3rd ed:American College of Chest Physicians evidence-based clinical practice guidelines[J].Chest,2013,143(5):93-120.
13 Zhang Y,Hong QY,Shi WB,et al.Value of low-dose spiral computed tomography in lung cancer screening[J].Zhonghua Yi Xue Za Zhi,2013,93(38):3011-3014.
14 Chen NA,Ma J.A multivariate risk factors analysis study contributing to solitary pulmonary nodules[J].Chin J Clinicians,2014,8(14):2602-2607.
15 Cho J,Kim ES,Kim SJ,et al.Long-term follow-up of small pulmonary ground-glass nodules stable for 3 years:implications of the proper follow-up period and risk factors for subsequent growth[J].J Thorac Oncol,2016,11(9):1453-1459.
16 Wen CP,Zhang F,Liang D,et al.The ability of bilirubin in identifying smokers with higher risk of lung cancer:a large cohort study in conjunction with global metabolomic profiling[J].Clin Cancer Res,2015,21(1):193-200.
17 Swensen SJ,Jett JR,Sloan JA,et al.Screening for lung cancer with low-dose spiral computed tomography[J].Am J Respir Crit Care Med,2002,165:508-513.
18 Kwon M,Lee SH,Lee YS,et al.Clinical implications of nonspecific pulmonary nodules identified during the initial evaluation of patients with head and neck squamous cell carcinoma[J].Eur Radiol,2017,27(9):3725-3732.
19 Gould MK,Ananth L,Barnett PG,et al.A clinical model to estimate the pretest probability of lung cancer in patients with solitary pulmonary nodules[J].Chest,2007,131(2):383-388.
20 Ten Haaf K,de Koning HJ.Should never-smokers at increased risk for lung cancer be screened?[J].J Thorac Oncol,2015,10(9):1285-1291.
21 唐威,吴宁,黄遥,等.4690例无症状健康体检者低剂量CT早期肺癌筛查研究[J].中华肿瘤杂志,2014,36(7):549-554.
22 Shinohara S,Hanagiri T,Takenaka M,et al.Evaluation of undiagnosed solitary lung nodules according to the probability of malignancy in the American College of Chest Physicians(ACCP)evidence-based clinical practice guidelines[J].Radiol Oncol,2014,48(1):50-55.
23 Mehta HJ,Ravenel JG,Shaftman SR,et al.The utility of nodule volume in the context of malignancy prediction for small pulmonary nodules[J].Chest,2014,145(3):464-472.
24 Detterbeck FC,Lewis SZ,Diekemper R,et al.Executive Summary:Diagnosis and management of lung cancer,3rded:American College of Chest Physicians evidence-based clinical practice guidelines[J].Chest,2013,143(5):7-37.
25 MacMahon H,Naidich DP,Goo JM,et al.Guidelines for management of incidental pulmonary nodules detected on ct images:from the fleischner society 2017[J].Radiology,2017,284(1):228-243.
26 Naidich DP,Bankier AA,Macmabon H,et al.Recommendations for the management of subsolid pulmonary nodules detedted at CT:a statement from the Fleischner Society[J].Radiology,2013,266(1):304-317.
27 Boiselle PM,White CS,Ravenel JG.Computed tomographic screening for lung cancer:current practice patterns at leading academic medical centers[J].JAMA Intern Med,2014,174(2):286-287.
28 Kim SY,Lee KS,Han J,et al.Persistent pulmonary nodular ground-glass opacity at thin-section CT histopathologic comparisons[J].Radiology,2007,245(1):267-275.
29 Mets OM,de Jong PA,Scholten ET,et al.Subsolid pulmonary nodule morphology and associated patient characteristics in a routine clinical population[J].Eur Radiol,2017,27(2):689-696.
30 Silva M,Bankier AA,Centra F,et al.Longitudinal evolution of incidentally detected solitary pure ground-glass nodules on CT:relation to clinical metrics[J].Diagn Interv Radiol,2015,21(5):385-390.
31 Bellier J,Perentes JY,Abdelnour-Berchtold E,et al.A plea for thoracoscopic resection of solitary pulmonary nodulein cancer patients[J].Surg Endosc,2017,31(11):4705-4710.
32 Horeweg N,van der Aalst CM,Thunnissen E,et al.Characteristics of lung cancers detected by computer tomography screening in the randomized NELSON trial[J].Am J Respir Crit Care Med,2013,187(8):848-854.
33 王欣悦,韩融诚,郭芳芳,等.不同类型肺结节的生长曲线分析[J].中国肺癌杂志,2017,20(5):334-340.
34 Winer-Muram HT.The solitary pulmonary nodule[J].Radiology,2006,239(1):34-49.
35 Yang W,Sun Y,Fang W,et al.High-resolution computed tomography features distinguishing benign and malignant lesions manifesting as persistent solitary subsolid nodules[J].Clin Lung Cancer,2017,7304(17)30172-30179.
36 喻微,叶波,续力云,等.实性孤立性肺结节诊断模型的建立[J].中国肺癌杂志,2016,10(19):705-710.

[1]	顾秀瑛，顾晓芬，朱俊宇，周天虹，朱琳. 2014-2016年乌鲁木齐市9265例城市居民肺癌筛查结果分析[J]. 实用肿瘤学杂志, 2017, 31(3): 242-245.
[2]	孙理, 张修石, 周洋, 刘露. 人工神经网络在孤立性肺结节良恶性诊断中的应用^△[J]. 实用肿瘤学杂志, 2011, 25(2): 126-128.

低剂量螺旋CT肺癌筛查及肺结节的研究现状

Current status:low dose spiral CT lung screening and pulmonary nodules

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 2

编辑推荐

Metrics

本文评价